Introduction

The COVID-19 pandemic is highly challenging for the operating room staff and healthcare workers in the emergency departments [1, 2]. Secondary transmission occurs primarily via inhalation of droplets or airborne particle transmission and is common in the hospital setting [3].

During aerosol-generating medical procedures (AGMP), the production of both airborne particles and droplets may increase the risk of infection.

The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) defined a list of AGMP, during which the use of personal protective equipment (PPE) should be recommended for all involved theater staff [4, 5].

PPE consists of head covering, eye protection, N95 mask, gloves, and long-sleeved gowns [6].

The main determinant of the risk of contagion is the total viral load in the secretions to whom the healthcare workers are exposed. For this reason, it is strongly recommended to limit as much as possible the period of close-proximity to the patients.

With this regard, the “Aerosol Box” (AB) has been claimed as a valuable protective resource during open suctioning of airways and endotracheal intubation or extubation [7].

This system, originally designed by a Taiwanese doctor on a simple cuboid with two access ports for arms [7], appears as a low cost, space-efficient and easy to set up a solution to restrict the area of contact against expelled aerosol particles [7, 8]. AB consists of a disposable polycarbonate sheet box, which can be re-used after careful decontamination with an appropriate cleansing agent.‬‬‬‬‬‬

In this study, we focus on the role of PPE and AB in preventing transmission among operating room staff.

Patients and outcomes

We report a retrospective case series of six COVID-19 positive male patients undergoing emergent surgical treatment for gastrointestinal complications. Clinical, operative, and postoperative details are described in Table 1.

Table 1 Patients’ characteristics
Full size table

Prior to surgery, the diagnosis of COVID-19 was confirmed by reverse transcription–polymerase chain reaction (RT-PCR) testing and chest computed tomography.

All intubations were undertaken under video-laryngoscope guidance through a 60 cm × 60 cm × 40 cm polycarbonate sheet AB (Figs. 1, 2) with 4 circular (2 lateral and 2 posterior) ports.

Fig. 1
figure 1

The Aerosol Box (60 × 60 × 40 cm)

Full size image
Fig. 2
figure 2

The use of the Aerosol Box during endotracheal intubation under video-laryngoscope guidance

Full size image

All laparoscopic procedures were performed in a negative pressure room by minimizing the use of electrocautery, reducing the trocars-size, and using the appropriate devices to filter released CO2 for aerosolized particles [9]. Post-operative admission to the intensive care unit (ICU) for mechanical ventilation was planned for all patients.

Discussion

The novel coronavirus disease affects predominantly the upper airways, but gastrointestinal symptoms (GIs) occur in up to one-third of patients. A recent meta-analysis including 60 studies and 4243 patients from six countries reported a prevalence of GIs of 17.6% [10]. Interestingly, almost half of the patients’ stool sample tested positive for novel coronavirus RNA.

The high rate of small bowel involvement in our series is probably due to the expression of angiotensin-converting enzyme (ACE)-2 receptors on the brush border of enterocytes [11]. Furthermore, ischemic complications are related to both the hypercoagulability state and the endothelial injury caused by COVID-19.

The mortality rate was consistent with that reported by Kaafarani et al. [12] and maybe credited to the delayed surgical treatment resulting from the patient’s fear and health system overload [13].

Intubation is a high-risk aerosolizing procedure [4, 5]. A recent report emphasizes the looming threat of COVID-19 infection to complicate the course of patients undergoing surgery [14]. At the same time, the risk of surgical team members' cross-infecting patients and other staff is high [6].

Respiratory protection is mandatory during the COVID-19 pandemic even if the evidence on PPE effectiveness is still low. In fact, two randomized controlled trials showed no differences in terms of infection rate among surgical masks and N95 [15, 16].

A recently developed global guidance for surgical care advises on the use of local protocols for PPE in the operating theatre, including scrubbing, donning, and doffing techniques [6].

It still remains uncertain whether COVID-19 can be found in abdominal fluids or aerosols created during gas insufflation. Decision making and agreed procedural steps for gaining access into the abdominal cavity strictly depend on such understanding.

The risk of transmission of COVID-19 during laparoscopy remains theoretical but cannot be ruled out, given oral, nasal, and ocular exposure. For this reason, it is good practice to check all instruments and the proper functioning of the suction system before starting the procedure; to use balloon trocars and create suitable holes for leak-free trocars insertion; to avoid leaks of smoke obstructing the surgical field, which should be removed via the vacuum suction device; and to fully deflate pneumoperitoneum before making a service incision, and at the end of the procedure prior to trocar extraction [9].

Exposure to aerosol droplets represents a further potential source of infection when inserting or removing an endotracheal tube in the theatre.

Nevertheless, the Aerosol Box has raised some criticism concerning its innate features, namely that one box size does not fit all and the inability to warrant accurate manipulation of a gum elastic bougie or any other device used in securing an airway [17]. High-quality evidence supporting any aspect of PPE is lacking [18]. Innovation should be encouraged, but caution should be applied.

Conclusions

Considering the high risk of disease transmission during AGMP, we support the use of both PPE and AB to protect surgical staff during the current COVID-19 outbreak.